Synthesis and biological activity of novel 1H,3H-thiazolo[3,4-a]benzimidazoles: Non-nucleoside human immunodeficiency virus type 1 reverse transcriptase inhibitors

Antiviral Chemistry and Chemotherapy

Volumn 10, Issue 4, 1999, Pages 211-217

  Chimirri, A ^a   Grasso, S ^a   Monforte, P ^a   Rao, A ^a   Zappala M ^a   Monforte, A M ^b   Pannecouque, C ^c   Witvrouw, M ^c   Balzarini, J ^c   De Clercq, E ^c  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^c REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

1H,3H thiazolo 3,4 a benzimidazoles; Anti HIV activity; NNRTIs; TBZs

Indexed keywords

1 (2,6 DIFLUOROPHENYL) 1H,3H THIAZOLO[3,4 A]BENZIMIDAZOLE; BENZIMIDAZOLE DERIVATIVE; RNA DIRECTED DNA POLYMERASE; RNA DIRECTED DNA POLYMERASE INHIBITOR; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG DESIGN; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME INHIBITION; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

EID: 0032772910     PISSN: 09563202     EISSN: None     Source Type: Journal    
DOI: 10.1177/095632029901000405     Document Type: Article

References (16)

1. Artico M (1996) Non-nucleoside anti-HIV-1 reverse transcriptase inhibitors (NNRTIs): a chemical survey from lead compounds to selected drugs for clinical trials. Il Farmaco 51:305-331.
2. Balzarini J, Pérez-Pérez MJ, San-Félix A, Camarasa MJ, Bathurst IC, Barr PJ & De Clercq E (1992) Kinetics of inhibition of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase by the novel HIV-1-specific nucleoside analogue [2′,5′-bis-O-(tert-butyldimethylsilyl)-beta-D-ribofuranosyl]- 3′-spiro-5″-(4″-amino-1″,2″-oxathiole-2″, 2″-dioxide)thymine (TSAO-T). Journal of Biological Chemistry 267:11831-11838.
3. Buckheit RW, Hollingshead MG, Germany-Decker J, White EL, McMahon JB, Allen LB, Ross LJ, Decker WD, Westbrook L, Shannon WM, Weislow O, Badet JP & Boyd MR (1993) Thiazolobenzimidazole: biological and biochemical anti-retroviral activity of a new nonnucleoside reverse transcriptase inhibitor. Antiviral Research 21:247-265.
4. Chimirri A, Grasso S, Monforte AM, Monforte P & Zappalà M (1991a) Anti-HIV agents I. Synthesis and anti-HIV evaluation of novel 1H,3H-thiazolo[3,4-a]benzimidazoles. Il Farmaco 46:817-823.
5. Chimirri A, Grasso S, Monforte AM, Monforte P & Zappalà M (1991b) Anti-HIV agents II. Synthesis and in vitro anti-HIV activity of novel 1H,3H-thiazolo[3,4-a]benzimidazoles. Il Farmaco 46:925-933.
6. Chimirri A, Grasso S, Molica C, Monforte AM, Monforte P, Zappalà M & Scopelliti R (1996) Anti-HIV agents IV. Synthesis and in vitro anti-HIV activity of novel 1-(2,6-difluorophenyl)-1H,3H-thiazolo[3,4-a]benzimidazoles. Il Farmaco 51:279-282.
7. Chimirri A, Grasso S, Molica C, Monforte AM, Monforte P, Zappalà M, Bruno G, Nicolò F, Witvrouw M, Jonckeere H, Balzarini J & De Clercq E (1997a) Structural features and anti-human immunodeficiency virus (HIV) activity of the isomers of 1-(2′,6′-difluorophenyl)-1H,3H-thiazolo[3,4-a]benzimidazole, a potent non-nucleoside HIV-1 reverse transcriptase inhibitor. Antiviral Chemistry & Chemotherapy 8:363-370.
8. Chimirri A, Grasso S, Monforte AM, Monforte P, Rao A., Zappalà M, Bruno G, Nicolò F & Scopelliti R (1997b) Anti-HIV agents V. Synthesis, structure and in vitro anti-HIV activity of novel 1H,3H-naphtho[2′,3′:4,5]imidazo[1,2-c]thiazoles. Il Farmaco 52:673-677.
9. Chimirri A, Grasso S, Monforte AM, Monforte P, Rao A, Zappalà M, Bruno G, Nicolò F, Pannecouque C, Witvrouw M & De Clercq E (1998) Synthesis, structure and in vitro anti-human immunodeficiency virus activity of novel 3-methyl-1H,3H-thiazolo[3,4-a]benzimidazole. Antiviral Chemistry & Chemotherapy 9:431-438.
10. Esnouf R, Ren J, Ross C, Jones Y, Stammers D & Stuart D (1995) Mechanism of inhibition of HIV-1 reverse transcriptase by non-nucleoside inhibitors. Nature Structural Biology 2:303-308.
11. Le Grice SFJ (1993) Human immunodeficiency virus reverse transcriptase. In Reverse Transcriptase, pp. 163-191. Edited by AM Skalka and SP Goff. Plainview, NY: Cold Spring Harbor Laboratory Press.
12. Pauwels R, Balzarini J, Baba M, Snoeck R, Schols D, Herdewijin P, Desmyter J & De Clercq E (1988) Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds. Journal of Virological Methods 20:309-321.
13. Schultz RJ, Bader JP, Chimirri A, Covey JM, Hill DL, Haugwitz RD, Guziec FS & Narayanan VL (1992) Thiazolobenzimidazoles - a new class of anti-HIV agents. Proceedings of the American Association for Cancer Research 33:517.
14. Spence RA, Kati WM, Anderson KS & Johnson KA (1995) Mechanism of inhibition of HIV-1 reverse transcriptase by non-nucleoside inhibitors. Science 267:988-993
15. Tantillo C, Ding J, Jacobo-Molina A, Nanni RG, Boyer PL, Hughes SH, Pauwels R, Andries K, Janssen PA & Arnold E (1994) Locations of anti-AIDS drug binding sites and resistance mutations in the three-dimensional structure of HIV-1 reverse transcriptase: implication for mechanisms of drug inhibition and resistance. Journal of Molecular Biology 243:369-387.
16. Witvrouw M, Schols D, Andrei G, Snoeck R, Hosoya M, Pauwels R, Balzarini J & De Clercq E (1991) Antiviral activity of low-MW dextran sulfate (derived from dextran MW 1000) compared to dextran sulfate samples of higher MW. Antiviral Chemistry & Chemotherapy 2:171-179.